Sarah Mason

5.2k total citations · 1 hit paper
75 papers, 3.0k citations indexed

About

Sarah Mason is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Sarah Mason has authored 75 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Neurology. Recurrent topics in Sarah Mason's work include Veterinary Oncology Research (16 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Prenatal Screening and Diagnostics (10 papers). Sarah Mason is often cited by papers focused on Veterinary Oncology Research (16 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Prenatal Screening and Diagnostics (10 papers). Sarah Mason collaborates with scholars based in United Kingdom, Canada and United States. Sarah Mason's co-authors include Roger A. Barker, Caroline H. Williams‐Gray, Jonathan Evans, Thomas Foltynie, Trevor W. Robbins, Carol Brayne, Jessica Barrett, Anders Björklund, Gavin P. Reynolds and Neil McNaughton and has published in prestigious journals such as Brain, American Journal of Clinical Nutrition and Neurology.

In The Last Decade

Sarah Mason

69 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

2013 469 citations Caroline H. Williams‐Gray, Sarah Mason et al. Journal of Neurology Neurosurgery & Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Mason United Kingdom	28	1.1k	673	673	483	475	75	3.0k
Ilan Shelef Israel	31	703 0.6×	831 1.2×	366 0.5×	293 0.6×	511 1.1×	181	3.6k
Natan Gadoth Israel	30	608 0.6×	510 0.8×	353 0.5×	546 1.1×	531 1.1×	150	3.1k
Ian J. Butler United States	35	677 0.6×	1.2k 1.8×	1.1k 1.6×	478 1.0×	349 0.7×	111	4.1k
Arun B. Taly India	28	724 0.7×	481 0.7×	379 0.6×	282 0.6×	311 0.7×	180	3.0k
Wang‐Tso Lee Taiwan	34	338 0.3×	977 1.5×	588 0.9×	339 0.7×	440 0.9×	199	3.9k
Shoji Tsuji Japan	31	671 0.6×	1.2k 1.8×	957 1.4×	211 0.4×	442 0.9×	194	3.6k
Louis Vallée France	29	409 0.4×	728 1.1×	495 0.7×	298 0.6×	361 0.8×	157	2.9k
Aviva Fattal‐Valevski Israel	31	945 0.9×	524 0.8×	243 0.4×	249 0.5×	211 0.4×	130	3.3k
Ki Joong Kim South Korea	28	490 0.5×	892 1.3×	396 0.6×	236 0.5×	226 0.5×	199	3.0k
Alfons Macaya Spain	32	627 0.6×	1.3k 1.9×	909 1.4×	97 0.2×	389 0.8×	126	3.5k

Countries citing papers authored by Sarah Mason

Since Specialization

Citations

This map shows the geographic impact of Sarah Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Mason more than expected).

Fields of papers citing papers by Sarah Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Mason. The network helps show where Sarah Mason may publish in the future.

Co-authorship network of co-authors of Sarah Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Mason. A scholar is included among the top collaborators of Sarah Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Mason. Sarah Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahon, Elizabeth, et al.. (2022). Case Report: Ventriculoperitoneal Shunting and Radiation Therapy Treatment in a Cat With a Suspected Choroid Plexus Tumor and Hypertensive Hydrocephalus. Frontiers in Veterinary Science. 9. 828083–828083. 1 indexed citations

Shimizu, Naomi, et al.. (2022). Case Report: A Novel Lateral Approach to the C7, C8, and T1 Intervertebral Foramina for Resection of Malignant Peripheral Nerve Sheath Neoplasia, Followed by Adjunctive Radiotherapy, in Three Dogs. Frontiers in Veterinary Science. 9. 869082–869082. 3 indexed citations

Mason, Sarah, et al.. (2021). Diagnostic imaging, treatment and outcome in a 14‐month‐old Dobermann with brainstem gemistocytic astrocytoma. Veterinary Record Case Reports. 9(4). 1 indexed citations

Mason, Sarah, et al.. (2021). Outcomes of adjunctive radiation therapy for the treatment of mast cell tumors in dogs and assessment of toxicity: A multicenter observational study of 300 dogs. Journal of Veterinary Internal Medicine. 35(6). 2853–2864. 6 indexed citations

Southworth, Thomas, Sarah Mason, Isabel Ramis, et al.. (2018). PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge. Biomarker Research. 6(1). 14–14. 25 indexed citations

Mason, Sarah, et al.. (2018). Evaluation of a multi‐agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non‐Hodgkin high‐grade lymphomas. Veterinary and Comparative Oncology. 16(3). 361–369. 10 indexed citations

Mason, Sarah, Riccardo Finotello, & Laura Blackwood. (2017). Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy. Veterinary and Comparative Oncology. 16(1). E30–E37. 11 indexed citations

Stieb, David M., Robin Shutt, Lisa Marie Kauri, et al.. (2017). Cardio-Respiratory Effects of Air Pollution in a Panel Study of Outdoor Physical Activity and Health in Rural Older Adults. Journal of Occupational and Environmental Medicine. 59(4). 356–364. 27 indexed citations

Chitty, Lyn S., D. Wright, Melissa Hill, et al.. (2016). Uptake, Outcomes, and Costs of Implementing Non-invasive Prenatal Testing for Down Syndrome Into NHS Maternity Care: Prospective Cohort Study in Eight Diverse Maternity Units. Obstetrical & Gynecological Survey. 71(11). 637–639. 5 indexed citations

10.

Velseboer, Daan C., Rob M.A. de Bie, Luuk Wieske, et al.. (2016). Development and external validation of a prognostic model in newly diagnosed Parkinson disease. Neurology. 86(11). 986–993. 38 indexed citations

11.

Chitty, Lyn S., Sarah Mason, Angela N. Barrett, et al.. (2015). Non‐invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next‐generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenatal Diagnosis. 35(7). 656–662. 112 indexed citations

12.

Hill, Melissa, Philip Twiss, Talitha I. Verhoef, et al.. (2015). Non‐invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. Prenatal Diagnosis. 35(10). 950–958. 61 indexed citations

13.

Hill, Melissa, D. Wright, Rebecca Daley, et al.. (2014). Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC Pregnancy and Childbirth. 14(1). 229–229. 61 indexed citations

14.

Williams‐Gray, Caroline H., Sarah Mason, Jonathan Evans, et al.. (2013). The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. Journal of Neurology Neurosurgery & Psychiatry. 84(11). 1258–1264. 469 indexed citations breakdown →

15.

Mason, Sarah, et al.. (2012). MAFMAD men (and women) in road safety advertising: Are user created messages superior?. RMIT Research Repository (RMIT University Library). 1 indexed citations

16.

Mason, Sarah, et al.. (2012). In vitro digestion of red deer (Cervus elaphus) and cow (Bos taurus) milk.. International Food Research Journal. 19(4). 1367–1374. 10 indexed citations

17.

McColgan, Peter, Jonathan Evans, David P. Breen, et al.. (2012). Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease. Movement Disorders. 27(9). 1173–1177. 33 indexed citations

18.

Barker, Roger A., Jessica Barrett, Sarah Mason, & Anders Björklund. (2012). Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. The Lancet Neurology. 12(1). 84–91. 255 indexed citations

19.

Evans, Jonathan, Sarah Mason, Caroline H. Williams‐Gray, et al.. (2011). The Factor Structure of the UPDRS as an Index of Disease Progression in Parkinson's Disease. Journal of Parkinson s Disease. 1(1). 75–82. 19 indexed citations

20.

Floyd, Rachel V., Sarah Mason, C. J. PROUDMAN, et al.. (2007). Expression and nephron segment-specific distribution of major renal aquaporins (AQP1–4) inEquus caballus, the domestic horse. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 293(1). R492–R503. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact